LEADER 03462nam  22006015  450 
001 9910733732203321
005 20230613073922.0
010   $a3-030-01099-6
024 7 $a10.1007/978-3-030-01099-7
035   $a(CKB)4930000000042006
035   $a(MiAaPQ)EBC5742747
035   $a(DE-He213)978-3-030-01099-7
035   $a(PPN)235232882
035   $a(EXLCZ)994930000000042006
100   $a20190328d2019      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aProgress in the Chemistry of Organic Natural Products 108 /$fedited by A. Douglas Kinghorn, Heinz Falk, Simon Gibbons, Jun'ichi Kobayashi, Yoshinori Asakawa, Ji-Kai Liu
205   $a1st ed. 2019.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019.
215   $a1 online resource (301 pages)
225 1 $aProgress in the Chemistry of Organic Natural Products,$x2192-4309 ;$v108
311   $a3-030-01098-8 
327   $aChemistry and biology of selected Mexican medicinal plants -- Biomolecular targets of oxyprenylated phenylpropanoids and polyketides -- Secondary metabolites of endophytic actinomycetes: isolation, synthesis, biosynthesis, and biological activities.
330   $aThe first contribution summarizes current trends in research on medicinal plants in Mexico with emphasis on work carried out at the authors' laboratories. The most relevant phytochemical and pharmacological profiles of a selected group of plants used widely for treating major national health problems are described. The second contribution provides a detailed survey of the so far reported literature data on the capacities of selected oxyprenylated phenylpropanoids and polyketides to trigger receptors, enzymes, and other types of cellular factors for which they exhibit a high degree of affinity and therefore evoke specifice responses. And the third contribution discusses aspects of endophytic actinobacterial biology and chemistry, including biosynthesis and total synthesis of secondary metabolites produced in culture. It also presents perspectives fo the future of microbial biodiscovery, with emphasis on the seondary metabolism of endophytic actinobacteria.
410  0$aProgress in the Chemistry of Organic Natural Products,$x2192-4309 ;$v108
606   $aChemistry, Organic
606   $aPharmaceutical chemistry
606   $aMedicinal chemistry
606   $aOrganic Chemistry
606   $aPharmaceutics
606   $aMedicinal Chemistry
615  0$aChemistry, Organic.
615  0$aPharmaceutical chemistry.
615  0$aMedicinal chemistry.
615 14$aOrganic Chemistry.
615 24$aPharmaceutics.
615 24$aMedicinal Chemistry.
676   $a547
676   $a547
702   $aKinghorn$b A. Douglas$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aFalk$b Heinz$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aGibbons$b Simon$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aKobayashi$b Jun'ichi$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aAsakawa$b Yoshinori$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aLiu$b Ji-Kai$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910733732203321
996   $aProgress in the Chemistry of Organic Natural Products 108$92528523
997   $aUNINA